 | • レポートコード：MRC2102QY16093 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：材料、化学 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のビンブラスチン硫酸塩市場について種類別（>98％ビンブラスチン硫酸塩、97～98％ビンブラスチン硫酸塩、その他）、用途別（リンパ腫、肺がん、乳がん、卵巣がん、白血病、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ビンブラスチン硫酸塩市場の概要 ・世界の主要地域別ビンブラスチン硫酸塩市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のビンブラスチン硫酸塩市場規模2015-2026：種類別（>98％ビンブラスチン硫酸塩、97～98％ビンブラスチン硫酸塩、その他） ・世界のビンブラスチン硫酸塩市場規模2015-2026：用途別（リンパ腫、肺がん、乳がん、卵巣がん、白血病、その他） ・ビンブラスチン硫酸塩の米国市場規模2015-2020 ・ビンブラスチン硫酸塩のヨーロッパ市場規模2015-2020 ・ビンブラスチン硫酸塩の中国市場規模2015-2020 ・ビンブラスチン硫酸塩の日本市場規模2015-2020 ・ビンブラスチン硫酸塩の東南アジア市場規模2015-2020 ・ビンブラスチン硫酸塩のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ビンブラスチン硫酸塩の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ビンブラスチン硫酸塩の市場動向・機会・課題 ・調査の結論 |
Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin’s disease, non-Hodgkin’s lymphoma (cancer of the lymph cells), Kaposi’s sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
Periwinkle Plantation is mainly concentrated in China. The production volume was high during 2000s, with a kilo of Vinca alkaloids can be sold at 10 USD/gram. Now as the less plantation in Hainan Province, the cost of Periwinkle and Vinca alkaloids has hiked at 20 USD/ gram. Currenly there are less companies produce Vinca alkaloids, since many companies couldn’t survive after capital chain breaks. Globally, leading suppliers are Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology and Guangzhou Person Pharmaceutical which are located in China. The three companies produced nealy 60% of global Vinblastinesulphate Vinkem from India also produce Vinblastinesulphate API for cancer treatment drugs.
Market Analysis and Insights: Global Vinblastinesulphate (CAS 143-67-9) Market
The global Vinblastinesulphate (CAS 143-67-9) market size is projected to reach US$ 21 million by 2026, from US$ 19 million in 2020, at a CAGR of 1.1% during 2021-2026.
Global Vinblastinesulphate (CAS 143-67-9) Scope and Market Size
The global Vinblastinesulphate (CAS 143-67-9) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vinblastinesulphate (CAS 143-67-9) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Vinblastinesulphate (CAS 143-67-9) market is segmented into
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Segment by Application, the Vinblastinesulphate (CAS 143-67-9) market is segmented into
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
The Vinblastinesulphate (CAS 143-67-9) market is analysed and market size information is provided by regions (countries). Segment by Application, the Vinblastinesulphate (CAS 143-67-9) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Vinblastinesulphate (CAS 143-67-9) Market Share Analysis
Vinblastinesulphate (CAS 143-67-9) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Vinblastinesulphate (CAS 143-67-9) business, the date to enter into the Vinblastinesulphate (CAS 143-67-9) market, Vinblastinesulphate (CAS 143-67-9) product introduction, recent developments, etc.
The major vendors covered:
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
1 Vinblastinesulphate (CAS 143-67-9) Market Overview
1.1 Vinblastinesulphate (CAS 143-67-9) Product Scope
1.2 Vinblastinesulphate (CAS 143-67-9) Segment by Type
1.2.1 Global Vinblastinesulphate (CAS 143-67-9) Sales by Type (2020-2026)
1.2.2 >98% Vinblastinesulphate
1.2.3 97-98% Vinblastinesulphate
1.2.4 Other
1.3 Vinblastinesulphate (CAS 143-67-9) Segment by Application
1.3.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Comparison by Application (2020-2026)
1.3.2 Lymphoma
1.3.3 Lung Cancer
1.3.4 Breast & Ovarian Cancer
1.3.5 Leukemia
1.3.6 Other
1.4 Vinblastinesulphate (CAS 143-67-9) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Growth Rate (2015-2026)
1.4.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2015-2026)
1.4.3 Global Vinblastinesulphate (CAS 143-67-9) Price Trends (2015-2026)
2 Vinblastinesulphate (CAS 143-67-9) Estimate and Forecast by Region
2.1 Global Vinblastinesulphate (CAS 143-67-9) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Vinblastinesulphate (CAS 143-67-9) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Region (2015-2020)
2.2.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Region (2015-2020)
2.3 Global Vinblastinesulphate (CAS 143-67-9) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Vinblastinesulphate (CAS 143-67-9) Estimates and Projections (2015-2026)
2.4.2 Europe Vinblastinesulphate (CAS 143-67-9) Estimates and Projections (2015-2026)
2.4.3 China Vinblastinesulphate (CAS 143-67-9) Estimates and Projections (2015-2026)
2.4.4 Japan Vinblastinesulphate (CAS 143-67-9) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Vinblastinesulphate (CAS 143-67-9) Estimates and Projections (2015-2026)
2.4.6 India Vinblastinesulphate (CAS 143-67-9) Estimates and Projections (2015-2026)
3 Global Vinblastinesulphate (CAS 143-67-9) Competition Landscape by Players
3.1 Global Top Vinblastinesulphate (CAS 143-67-9) Players by Sales (2015-2020)
3.2 Global Top Vinblastinesulphate (CAS 143-67-9) Players by Revenue (2015-2020)
3.3 Global Vinblastinesulphate (CAS 143-67-9) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vinblastinesulphate (CAS 143-67-9) as of 2019)
3.4 Global Vinblastinesulphate (CAS 143-67-9) Average Price by Company (2015-2020)
3.5 Manufacturers Vinblastinesulphate (CAS 143-67-9) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Vinblastinesulphate (CAS 143-67-9) Players (Opinion Leaders)
4 Global Vinblastinesulphate (CAS 143-67-9) Market Size by Type
4.1 Global Vinblastinesulphate (CAS 143-67-9) Historic Market Review by Type (2015-2020)
4.1.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
4.1.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Type (2015-2020)
4.1.3 Global Vinblastinesulphate (CAS 143-67-9) Price by Type (2015-2020)
4.2 Global Vinblastinesulphate (CAS 143-67-9) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Type (2021-2026)
4.2.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue Forecast by Type (2021-2026)
4.2.3 Global Vinblastinesulphate (CAS 143-67-9) Price Forecast by Type (2021-2026)
5 Global Vinblastinesulphate (CAS 143-67-9) Market Size by Application
5.1 Global Vinblastinesulphate (CAS 143-67-9) Historic Market Review by Application (2015-2020)
5.1.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2015-2020)
5.1.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Application (2015-2020)
5.1.3 Global Vinblastinesulphate (CAS 143-67-9) Price by Application (2015-2020)
5.2 Global Vinblastinesulphate (CAS 143-67-9) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Application (2021-2026)
5.2.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue Forecast by Application (2021-2026)
5.2.3 Global Vinblastinesulphate (CAS 143-67-9) Price Forecast by Application (2021-2026)
6 United States Vinblastinesulphate (CAS 143-67-9) Market Facts & Figures
6.1 United States Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company (2015-2020)
6.2 United States Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
6.3 United States Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2015-2020)
7 Europe Vinblastinesulphate (CAS 143-67-9) Market Facts & Figures
7.1 Europe Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company (2015-2020)
7.2 Europe Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
7.3 Europe Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2015-2020)
8 China Vinblastinesulphate (CAS 143-67-9) Market Facts & Figures
8.1 China Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company (2015-2020)
8.2 China Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
8.3 China Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2015-2020)
9 Japan Vinblastinesulphate (CAS 143-67-9) Market Facts & Figures
9.1 Japan Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company (3015-3030)
9.2 Japan Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
9.3 Japan Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2015-2020)
10 Southeast Asia Vinblastinesulphate (CAS 143-67-9) Market Facts & Figures
10.1 Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2015-2020)
11 India Vinblastinesulphate (CAS 143-67-9) Market Facts & Figures
11.1 India Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company (2015-2020)
11.2 India Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
11.3 India Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Vinblastinesulphate (CAS 143-67-9) Business
12.1 Guangzhou Hanfang Pharmaceutical
12.1.1 Guangzhou Hanfang Pharmaceutical Corporation Information
12.1.2 Guangzhou Hanfang Pharmaceutical Business Overview
12.1.3 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Products Offered
12.1.5 Guangzhou Hanfang Pharmaceutical Recent Development
12.2 Hainan Vinca Biological Medicine Technology
12.2.1 Hainan Vinca Biological Medicine Technology Corporation Information
12.2.2 Hainan Vinca Biological Medicine Technology Business Overview
12.2.3 Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Products Offered
12.2.5 Hainan Vinca Biological Medicine Technology Recent Development
12.3 Guangzhou Person Pharmaceutical
12.3.1 Guangzhou Person Pharmaceutical Corporation Information
12.3.2 Guangzhou Person Pharmaceutical Business Overview
12.3.3 Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Products Offered
12.3.5 Guangzhou Person Pharmaceutical Recent Development
12.4 Hainan Yueyang Biotechnology
12.4.1 Hainan Yueyang Biotechnology Corporation Information
12.4.2 Hainan Yueyang Biotechnology Business Overview
12.4.3 Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Products Offered
12.4.5 Hainan Yueyang Biotechnology Recent Development
12.5 Hubei Honch Pharmaceutical
12.5.1 Hubei Honch Pharmaceutical Corporation Information
12.5.2 Hubei Honch Pharmaceutical Business Overview
12.5.3 Hubei Honch Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hubei Honch Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Products Offered
12.5.5 Hubei Honch Pharmaceutical Recent Development
12.6 Fine Chemicals Corporation
12.6.1 Fine Chemicals Corporation Corporation Information
12.6.2 Fine Chemicals Corporation Business Overview
12.6.3 Fine Chemicals Corporation Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Fine Chemicals Corporation Vinblastinesulphate (CAS 143-67-9) Products Offered
12.6.5 Fine Chemicals Corporation Recent Development
12.7 Hengtengfu Biological Products
12.7.1 Hengtengfu Biological Products Corporation Information
12.7.2 Hengtengfu Biological Products Business Overview
12.7.3 Hengtengfu Biological Products Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hengtengfu Biological Products Vinblastinesulphate (CAS 143-67-9) Products Offered
12.7.5 Hengtengfu Biological Products Recent Development
12.8 Vinkem
12.8.1 Vinkem Corporation Information
12.8.2 Vinkem Business Overview
12.8.3 Vinkem Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Vinkem Vinblastinesulphate (CAS 143-67-9) Products Offered
12.8.5 Vinkem Recent Development
13 Vinblastinesulphate (CAS 143-67-9) Manufacturing Cost Analysis
13.1 Vinblastinesulphate (CAS 143-67-9) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Vinblastinesulphate (CAS 143-67-9)
13.4 Vinblastinesulphate (CAS 143-67-9) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Vinblastinesulphate (CAS 143-67-9) Distributors List
14.3 Vinblastinesulphate (CAS 143-67-9) Customers
15 Market Dynamics
15.1 Vinblastinesulphate (CAS 143-67-9) Market Trends
15.2 Vinblastinesulphate (CAS 143-67-9) Opportunities and Drivers
15.3 Vinblastinesulphate (CAS 143-67-9) Market Challenges
15.4 Vinblastinesulphate (CAS 143-67-9) Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Vinblastinesulphate (CAS 143-67-9) Sales (Kg) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Vinblastinesulphate (CAS 143-67-9) Sales (Kg) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Vinblastinesulphate (CAS 143-67-9) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Region (2015-2020)
Table 5. Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Region (2015-2020)
Table 6. Global Vinblastinesulphate (CAS 143-67-9) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Vinblastinesulphate (CAS 143-67-9) Revenue Share by Region (2015-2020)
Table 8. Global Vinblastinesulphate (CAS 143-67-9) Sales (Kg) Forecast by Region (2021-2026)
Table 9. Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Vinblastinesulphate (CAS 143-67-9) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Vinblastinesulphate (CAS 143-67-9) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Vinblastinesulphate (CAS 143-67-9) (Kg) of Key Companies (2015-2020)
Table 13. Global Vinblastinesulphate (CAS 143-67-9) Sales Share by Company (2015-2020)
Table 14. Global Vinblastinesulphate (CAS 143-67-9) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Vinblastinesulphate (CAS 143-67-9) Revenue Share by Company (2015-2020)
Table 16. Global Vinblastinesulphate (CAS 143-67-9) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vinblastinesulphate (CAS 143-67-9) as of 2019)
Table 17. Global Vinblastinesulphate (CAS 143-67-9) Average Price (USD/g) of Key Company (2015-2020)
Table 18. Manufacturers Vinblastinesulphate (CAS 143-67-9) Manufacturing Sites and Area Served
Table 19. Manufacturers Vinblastinesulphate (CAS 143-67-9) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Vinblastinesulphate (CAS 143-67-9) Players
Table 22. Global Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Type (2015-2020)
Table 23. Global Vinblastinesulphate (CAS 143-67-9) Sales Share by Type (2015-2020)
Table 24. Global Vinblastinesulphate (CAS 143-67-9) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Vinblastinesulphate (CAS 143-67-9) Price (Kg) by Type (2015-2020)
Table 26. Global Vinblastinesulphate (CAS 143-67-9) Sales Share by Type (2021-2026)
Table 27. Global Vinblastinesulphate (CAS 143-67-9) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Vinblastinesulphate (CAS 143-67-9) Revenue Share by Type (2021-2026)
Table 29. Global Vinblastinesulphate (CAS 143-67-9) Price (Kg) by Type (2021-2026)
Table 30. Global Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Application (2015-2020)
Table 31. Global Vinblastinesulphate (CAS 143-67-9) Sales Share by Application (2015-2020)
Table 32. Global Vinblastinesulphate (CAS 143-67-9) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Vinblastinesulphate (CAS 143-67-9) Price (Kg) by Application (2015-2020)
Table 34. Global Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Application (2021-2026)
Table 35. Global Vinblastinesulphate (CAS 143-67-9) Sales Share by Application (2021-2026)
Table 36. Global Vinblastinesulphate (CAS 143-67-9) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Vinblastinesulphate (CAS 143-67-9) Revenue Share by Application (2021-2026)
Table 38. Global Vinblastinesulphate (CAS 143-67-9) Price (Kg) by Application (2021-2026)
Table 39. United States Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Company (2015-2020)
Table 40. United States Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company (2015-2020)
Table 41. United States Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Type (2015-2020)
Table 42. United States Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
Table 43. United States Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Application (2015-2020)
Table 44. United States Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2015-2020)
Table 45. Europe Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Company (2015-2020)
Table 46. Europe Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company (2015-2020)
Table 47. Europe Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Type (2015-2020)
Table 48. Europe Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
Table 49. Europe Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Application (2015-2020)
Table 50. Europe Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
Table 51. China Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Company (2015-2020)
Table 52. China Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company (2015-2020)
Table 53. China Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Type (2015-2020)
Table 54. China Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
Table 55. China Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Application (2015-2020)
Table 56. China Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2015-2020)
Table 57. Japan Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Company (2015-2020)
Table 58. Japan Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company (2015-2020)
Table 59. Japan Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Type (2015-2020)
Table 60. Japan Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
Table 61. Japan Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Application (2015-2020)
Table 62. Japan Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Company (2015-2020)
Table 64. Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Type (2015-2020)
Table 66. Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Type (2015-2020)
Table 68. Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2015-2020)
Table 69. India Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Company (2015-2020)
Table 70. India Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company (2015-2020)
Table 71. India Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Type (2015-2020)
Table 72. India Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type (2015-2020)
Table 73. India Vinblastinesulphate (CAS 143-67-9) Sales (Kg) by Application (2015-2020)
Table 74. India Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2015-2020)
Table 75. Guangzhou Hanfang Pharmaceutical Corporation Information
Table 76. Guangzhou Hanfang Pharmaceutical Description and Business Overview
Table 77. Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 78. Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Product
Table 79. Guangzhou Hanfang Pharmaceutical Recent Development
Table 80. Hainan Vinca Biological Medicine Technology Corporation Information
Table 81. Hainan Vinca Biological Medicine Technology Description and Business Overview
Table 82. Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 83. Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Product
Table 84. Hainan Vinca Biological Medicine Technology Recent Development
Table 85. Guangzhou Person Pharmaceutical Corporation Information
Table 86. Guangzhou Person Pharmaceutical Description and Business Overview
Table 87. Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 88. Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Product
Table 89. Guangzhou Person Pharmaceutical Recent Development
Table 90. Hainan Yueyang Biotechnology Corporation Information
Table 91. Hainan Yueyang Biotechnology Description and Business Overview
Table 92. Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 93. Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Product
Table 94. Hainan Yueyang Biotechnology Recent Development
Table 95. Hubei Honch Pharmaceutical Corporation Information
Table 96. Hubei Honch Pharmaceutical Description and Business Overview
Table 97. Hubei Honch Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 98. Hubei Honch Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Product
Table 99. Hubei Honch Pharmaceutical Recent Development
Table 100. Fine Chemicals Corporation Corporation Information
Table 101. Fine Chemicals Corporation Description and Business Overview
Table 102. Fine Chemicals Corporation Vinblastinesulphate (CAS 143-67-9) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 103. Fine Chemicals Corporation Vinblastinesulphate (CAS 143-67-9) Product
Table 104. Fine Chemicals Corporation Recent Development
Table 105. Hengtengfu Biological Products Corporation Information
Table 106. Hengtengfu Biological Products Description and Business Overview
Table 107. Hengtengfu Biological Products Vinblastinesulphate (CAS 143-67-9) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 108. Hengtengfu Biological Products Vinblastinesulphate (CAS 143-67-9) Product
Table 109. Hengtengfu Biological Products Recent Development
Table 110. Vinkem Corporation Information
Table 111. Vinkem Vinblastinesulphate (CAS 143-67-9) Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 112. Vinkem Description and Business Overview
Table 113. Vinkem Vinblastinesulphate (CAS 143-67-9) Product
Table 114. Vinkem Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Vinblastinesulphate (CAS 143-67-9) Distributors List
Table 118. Vinblastinesulphate (CAS 143-67-9) Customers List
Table 119. Vinblastinesulphate (CAS 143-67-9) Market Key Trends
Table 120. Vinblastinesulphate (CAS 143-67-9) Key Opportunities and Drivers
Table 121. Vinblastinesulphate (CAS 143-67-9) Market Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Vinblastinesulphate (CAS 143-67-9) Product Picture
Figure 2. Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Vinblastinesulphate (CAS 143-67-9) Market Share by Application in 2020 & 2026
Figure 6. Lymphoma Examples
Figure 7. Lung Cancer Examples
Figure 8. Breast & Ovarian Cancer Examples
Figure 9. Leukemia Examples
Figure 10. Other Examples
Figure 11. Global Vinblastinesulphate (CAS 143-67-9) Sales (Kg) Growth Rate (2015-2026)
Figure 12. Global Vinblastinesulphate (CAS 143-67-9) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Vinblastinesulphate (CAS 143-67-9) Price Trends Growth Rate (2015-2026) (USD/g)
Figure 14. Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Vinblastinesulphate (CAS 143-67-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Vinblastinesulphate (CAS 143-67-9) Sales (Kg) Growth Rate (2015-2026)
Figure 18. Europe Vinblastinesulphate (CAS 143-67-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Vinblastinesulphate (CAS 143-67-9) Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Vinblastinesulphate (CAS 143-67-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Vinblastinesulphate (CAS 143-67-9) Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Vinblastinesulphate (CAS 143-67-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Vinblastinesulphate (CAS 143-67-9) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Vinblastinesulphate (CAS 143-67-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Vinblastinesulphate (CAS 143-67-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Vinblastinesulphate (CAS 143-67-9) Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Vinblastinesulphate (CAS 143-67-9) Players Market Share by Revenue in Vinblastinesulphate (CAS 143-67-9) 2015 & 2019
Figure 29. Vinblastinesulphate (CAS 143-67-9) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Vinblastinesulphate (CAS 143-67-9) Revenue Share by Type (2015-2020)
Figure 31. Global Vinblastinesulphate (CAS 143-67-9) Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Vinblastinesulphate (CAS 143-67-9) Revenue Share by Application (2015-2020)
Figure 33. Global Vinblastinesulphate (CAS 143-67-9) Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type in 2019
Figure 35. United States Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type in 2019
Figure 36. Europe Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company in 2019
Figure 37. Europe Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type in 2019
Figure 38. Europe Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application in 2019
Figure 39. China Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company in 2019
Figure 40. China Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type in 2019
Figure 41. China Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application in 2019
Figure 42. Japan Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company in 2019
Figure 43. Japan Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type in 2019
Figure 44. Japan Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application in 2019
Figure 45. Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company in 2019
Figure 46. Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type in 2019
Figure 47. Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application in 2019
Figure 48. India Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Company in 2019
Figure 49. India Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Type in 2019
Figure 50. India Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Vinblastinesulphate (CAS 143-67-9)
Figure 53. Manufacturing Process Analysis of Vinblastinesulphate (CAS 143-67-9)
Figure 54. Vinblastinesulphate (CAS 143-67-9) Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
がん診断装置の世界市場レポート2020 Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical compan…- 低分子がん治療薬の世界市場レポート2020 Market Analysis and Insights: Global Small Molecule Cancer Drug Market The global Small Molecule Cancer Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Small Molecule Cancer Drug Scope and Market Size The global Sm…
- がん画像システムの世界市場レポート2020 Market Analysis and Insights: Global Cancer Imaging System Market The global Cancer Imaging System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Cancer Imaging System Scope and Market Size The global Cancer Imaging Sy…
- 人工心肺装置の世界市場レポート2020 Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation. The classification of artifici…
- がんヤヌスキナーゼ阻害剤の世界市場レポート2020 The pan-JAK inhibitor tofacitinib improves the delivery of therapeutic antibodies in cancer. Monoclonal antibodies and antibody-drug conjugates (ADCs) directed against tumor antigens are increasingly used for therapy in a variety of cancers. Market Analysis and Insights: Global Cancer Janus Kinase I…